Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Uko

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Nurse Practitioner|October 23, 2020
Recognizing and treating autosomal dominant polycystic kidney diseaseChigozie G Uko
Rheumatology International|January 1, 1986
Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotypingG Uko, F T Christiansen, R L Dawkins
British Medical Journal (Clinical Research Ed.)|September 17, 1983
Low C4 concentrations in insulin dependent diabetes mellitusR L Dawkins, G Uko, F T Christiansen, et al.
Experimental and Clinical Immunogenetics|January 1, 1988
HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritisR S Warlow, G Uko, D J Feeney, et al.
British Medical Journal (Clinical Research Ed.)|May 28, 1983
Low serum C4 concentrations in insulin dependent diabetes mellitusG Uko, F T Christiansen, R L Dawkins, et al.
Journal of Clinical Pathology|May 1, 1986
Reference ranges for serum C4 concentrations in subjects with and without C4 null allelesG Uko, F T Christiansen, R L Dawkins, et al.
Clinical and Experimental Immunology|November 1, 1985
CR1 deficiency in SLE: acquired or genetic?G Uko, R L Dawkins, P Kay, et al.
Tissue Antigens|May 1, 1985
Secondary Sjögren's syndrome and chromosome six markersR S Warlow, P H Kay, J McCluskey, et al.
Australian and New Zealand Journal of Medicine|October 1, 1983
Complement allotyping in SLE: association with C4A nullF T Christiansen, R L Dawkins, G Uko, et al.
Clinical and Experimental Immunology|February 1, 1986
Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf allelesR S Warlow, G Uko, J McCluskey, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Nurse Practitioner|October 23, 2020
Recognizing and treating autosomal dominant polycystic kidney diseaseChigozie G Uko
Rheumatology International|January 1, 1986
Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotypingG Uko, F T Christiansen, R L Dawkins
British Medical Journal (Clinical Research Ed.)|September 17, 1983
Low C4 concentrations in insulin dependent diabetes mellitusR L Dawkins, G Uko, F T Christiansen, et al.
Experimental and Clinical Immunogenetics|January 1, 1988
HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritisR S Warlow, G Uko, D J Feeney, et al.
British Medical Journal (Clinical Research Ed.)|May 28, 1983
Low serum C4 concentrations in insulin dependent diabetes mellitusG Uko, F T Christiansen, R L Dawkins, et al.
Journal of Clinical Pathology|May 1, 1986
Reference ranges for serum C4 concentrations in subjects with and without C4 null allelesG Uko, F T Christiansen, R L Dawkins, et al.
Clinical and Experimental Immunology|November 1, 1985
CR1 deficiency in SLE: acquired or genetic?G Uko, R L Dawkins, P Kay, et al.
Tissue Antigens|May 1, 1985
Secondary Sjögren's syndrome and chromosome six markersR S Warlow, P H Kay, J McCluskey, et al.
Australian and New Zealand Journal of Medicine|October 1, 1983
Complement allotyping in SLE: association with C4A nullF T Christiansen, R L Dawkins, G Uko, et al.
Clinical and Experimental Immunology|February 1, 1986
Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf allelesR S Warlow, G Uko, J McCluskey, et al.
Pageof 2